Developing live biotherapeutics that target the core drivers of disease

Developing better therapies through a deep understanding of human microbial ecology

As a leading developer of next-generation live biotherapeutic products, we combine clinical data, bioinformatics, and top-notch microbial science to develop synergistic combinations of bacteria that target diseases with high unmet medical need. By leveraging our proprietary Precision Symbiotics Platform™ and in-house GMP manufacturing capabilities, we have rationally designed microbial consortia to address medical conditions where the human microbiota plays a central role in disease prevention.